Cite
HARVARD Citation
Mease, P. et al. (n.d.). FRI0511 Secukinumab demonstrates consistent safety over long-term exposure in patients with psoriatic arthritis and moderate-to-severe plaque psoriasis: updated pooled safety analyses. Annals of the rheumatic diseases. p. 683. [Online].